BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 33087165)

  • 21. MiRNA-671-5p Promotes prostate cancer development and metastasis by targeting NFIA/CRYAB axis.
    Zhu Z; Luo L; Xiang Q; Wang J; Liu Y; Deng Y; Zhao Z
    Cell Death Dis; 2020 Nov; 11(11):949. PubMed ID: 33144585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer.
    Xiang J; Bian C; Wang H; Huang S; Wu D
    J Exp Clin Cancer Res; 2015 Jan; 34(1):8. PubMed ID: 25636908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. METTL3-mediated m6A modification of pri-miR-148a-3p affects prostate cancer progression by regulating TXNIP.
    Li G; Liu J; Wang Y; Liu H; Fu J; Zhao Y; Huang Y
    Environ Toxicol; 2023 Oct; 38(10):2377-2390. PubMed ID: 37449729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p.
    Chen X; Jiang J; Zhao Y; Wang X; Zhang C; Zhuan L; Zhang D; Zheng Y
    J Exp Clin Cancer Res; 2020 Jul; 39(1):133. PubMed ID: 32653032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of EZH2 in aerobic glycolysis of prostate cancer through miR-181b/HK2 axis.
    Tao T; Chen M; Jiang R; Guan H; Huang Y; Su H; Hu Q; Han X; Xiao J
    Oncol Rep; 2017 Mar; 37(3):1430-1436. PubMed ID: 28184935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis.
    Mu HQ; He YH; Wang SB; Yang S; Wang YJ; Nan CJ; Bao YF; Xie QP; Chen YH
    Clin Transl Oncol; 2020 Jan; 22(1):111-121. PubMed ID: 31667686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MALAT1 knockdown inhibits prostate cancer progression by regulating miR-140/BIRC6 axis.
    Hao T; Wang Z; Yang J; Zhang Y; Shang Y; Sun J
    Biomed Pharmacother; 2020 Mar; 123():109666. PubMed ID: 31935634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA LINC01207 promotes prostate cancer progression by downregulating microRNA-1972 and upregulating LIM and SH3 protein 1.
    Wang S; Qiu J; Wang L; Wu Z; Zhang X; Li Q; Jiang F
    IUBMB Life; 2020 Sep; 72(9):1960-1975. PubMed ID: 32726517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells.
    Chen Y; Pan C; Wang X; Xu D; Ma Y; Hu J; Chen P; Xiang Z; Rao Q; Han X
    Theranostics; 2021; 11(16):7640-7657. PubMed ID: 34335955
    [No Abstract]   [Full Text] [Related]  

  • 30. Downregulation of N
    Li J; Meng S; Xu M; Wang S; He L; Xu X; Wang X; Xie L
    Oncotarget; 2018 Jan; 9(3):3752-3764. PubMed ID: 29423080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. microRNA-211-mediated targeting of the INHBA-TGF-β axis suppresses prostate tumor formation and growth.
    Zhao Z; Wang K; Tan S
    Cancer Gene Ther; 2021 May; 28(5):514-528. PubMed ID: 33223523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-148-3p and miR-152-3p synergistically regulate prostate cancer progression via repressing KLF4.
    Feng F; Liu H; Chen A; Xia Q; Zhao Y; Jin X; Huang J
    J Cell Biochem; 2019 Oct; 120(10):17228-17239. PubMed ID: 31104329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR-9-5p/QKI-5 axis.
    Wu M; Huang Y; Chen T; Wang W; Yang S; Ye Z; Xi X
    J Cell Mol Med; 2019 Jan; 23(1):29-38. PubMed ID: 30565858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circ-UBR1 facilitates proliferation, metastasis, and inhibits apoptosis in breast cancer by regulating the miR-1299/CCND1 axis.
    Zhang L; Sun D; Zhang J; Tian Y
    Life Sci; 2021 Feb; 266():118829. PubMed ID: 33259864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-coding RNA PICSAR knockdown inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-125b/YAP1 axis.
    Lu X; Gan Q; Gan C; Zheng Y; Cai B; Li X; Li D; Yin G
    Life Sci; 2021 Jun; 274():118303. PubMed ID: 32841663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA.
    Shi X; Zhang W; Nian X; Lu X; Li Y; Liu F; Wang F; He B; Zhao L; Zhu Y; Ren S; Sun Y
    Int J Cancer; 2020 Jan; 146(2):475-486. PubMed ID: 31107971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-145 Modulates
    Yang Z; Li J; Feng G; Gao S; Wang Y; Zhang S; Liu Y; Ye L; Li Y; Zhang X
    J Biol Chem; 2017 Mar; 292(9):3614-3623. PubMed ID: 28104805
    [No Abstract]   [Full Text] [Related]  

  • 38. YTHDF2 protein stabilization by the deubiquitinase OTUB1 promotes prostate cancer cell proliferation via PRSS8 mRNA degradation.
    Zhao X; Lv S; Li N; Zou Q; Sun L; Song T
    J Biol Chem; 2024 Apr; 300(4):107152. PubMed ID: 38462165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.
    Colden M; Dar AA; Saini S; Dahiya PV; Shahryari V; Yamamura S; Tanaka Y; Stein G; Dahiya R; Majid S
    Cell Death Dis; 2017 Jan; 8(1):e2572. PubMed ID: 28125091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-31 inhibits tumor invasion and metastasis by targeting RhoA in human gastric cancer.
    Ge F; Wang C; Wang W; Liu W; Wu B
    Oncol Rep; 2017 Aug; 38(2):1133-1139. PubMed ID: 28656284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.